Jason Krantz

Current Position

Title: Founder & Executive Chairman Company: Definitive Healthcare Corp (NASDAQ: DH) Location: Framingham, Massachusetts

Professional Background

Jason Krantz is a serial healthcare entrepreneur with a track record of building data and analytics businesses in information-intensive healthcare markets. He started his first company, Infinata (branded as BioPharm Insight), in 1999 while a student at Harvard Business School. The SaaS platform provided pharmaceutical companies with proprietary databases and market intelligence for drug pipeline research and analysis. After bootstrapping the company for seven years, he successfully exited to the Financial Times Group/Pearson PLC in 2007.

In 2011, Krantz founded Definitive Healthcare to apply similar intelligence-driven approaches to the broader U.S. healthcare ecosystem. Under his leadership as CEO for over a decade, the company scaled to approximately 500-700 employees and 2,500+ customers, including 9 out of 10 top pharmaceutical, medical device, and biotechnology companies. The company achieved profitability and executed a successful IPO on NASDAQ in September 2021, raising $420 million at a valuation exceeding $4 billion. After transitioning to Executive Chairman in August 2022, Krantz briefly returned to serve as Interim CEO from January to June 2024 during a leadership transition.

Krantz's background also includes professional consulting experience as an associate at McKinsey & Company from 1995-1998, where he gained exposure to healthcare, technology, and financial services industries. He holds a Bachelor of Science in Finance and Computer Science from Boston College and an MBA from Harvard Business School.

Career Timeline

Education

• Bachelor of Science in Finance and Computer Science, Boston College
• Master of Business Administration, Harvard Business School

Public Presence

Social Media

Note: Only publicly accessible profiles are documented. Multiple other individuals named Jason Krantz exist on social media; this profile documents the Definitive Healthcare founder exclusively.

Published Writings

• "Meet The Disruptors: Jason Krantz Of Definitive Healthcare On The Five Things You Need To Shake Up Your Industry" — Authority Magazine/Medium (interview)
• Blog author contributions on Definitive Healthcare's website covering company culture, data intelligence, and healthcare market trends
• Various CEO insights and company updates on Definitive Healthcare corporate blog

Public Speaking

• Swaay.Health LIVE Conference speaker (recent)
• PathWise Podcast: "Jason Krantz, CEO of Definitive Healthcare" — discussion on scaling from startup to public company
• HIStalk Interview: Healthcare IT market trends and Definitive Healthcare's platform strategy (2019)
• Health Business Group Interview: Definitive Healthcare strategy and market dynamics (2022)
• Boston College Alumni Events: Lunch and networking sessions for current students discussing entrepreneurial journey
• Healthcare industry conferences and investment forums as company representative

Communication Style

Tone: Professional, pragmatic, and focused on business fundamentals. Krantz communicates with confidence grounded in data and market expertise rather than hyperbole. His language suggests a methodical, strategy-first mindset combined with genuine concern for organizational culture and community impact.

Recurring themes: Krantz frequently emphasizes the importance of high-quality data and analytics as competitive advantages in healthcare markets. He champions the role of commercial intelligence in helping organizations navigate complex healthcare ecosystems. He highlights company culture and employee engagement as critical to scaling, frequently referencing the DefinitiveCares volunteer program as evidence that business success and community values are interconnected. His messaging balances growth ambitions with community responsibility.

Notable positions: Krantz is an advocate for data-driven decision-making in healthcare and positions Definitive Healthcare as a trusted intelligence provider that helps companies make better strategic and commercial decisions. He emphasizes that building sustainable businesses requires attention to culture and values alongside financial performance, particularly during hypergrowth phases. He supports mental health and addiction treatment accessibility, as evidenced by his significant investment in Recovery.com.

Krantz's communication style reflects someone shaped by both consulting (McKinsey) and entrepreneurship. He demonstrates a comfort with complexity and an ability to distill strategic insights—hallmarks of his McKinsey background—while also displaying the pragmatic, customer-focused orientation of someone who has built and scaled multiple businesses from the ground up. When discussing business topics, he focuses on executable strategies, competitive positioning, and market fundamentals rather than vision statements or buzzwords. In interviews about company culture and growth, his communication becomes more personal and reflective, suggesting genuine investment in people and organizational values beyond shareholder returns.

Notable Achievements

• Founded and scaled Infinata (BioPharm Insight) from bootstrap to successful acquisition by Pearson/Financial Times Group (1999-2007)
• Founded Definitive Healthcare in 2011; grew company to 500+ employees and 2,500+ customers before IPO
• Led Definitive Healthcare's successful NASDAQ IPO in September 2021, raising $420 million at $4 billion+ valuation
• 2020 EY Entrepreneur of the Year Award Winner, New England region
• EY Entrepreneur of the Year finalist (appeared multiple times in the finalist pool)
• Pioneered healthcare data-as-a-service category, positioning Definitive Healthcare as the leading commercial intelligence provider to U.S. healthcare industry
• Built culture-first organization with DefinitiveCares volunteer program (established 2015), creating structured community engagement opportunities across 500+ employees
• Strategic acquisition and integration leadership: successfully acquired and integrated US Lifeline, Billian's HealthDATA, HIMSS Analytics data services, and PatientFinder into Definitive Healthcare platform

Key Relationships

• Investor and Board Member: Boston College Board of Trustees, Massachusetts General Hospital President's Council
• Active Board Positions: FINTRX (Series A investor, led $9M funding round), MDCalc
• Recent Investment: Recovery.com (7% stake in 2024, joined board of directors; total investment of $15 million as of late 2024); also brought Joe Mirisola (Definitive Healthcare's first employee and former CRO) to Recovery.com's ownership group
• Professional Associations: Frequent speaker and mentor to healthcare industry entrepreneurs and executives
• Spectrum Equity Partnership: Backed by Spectrum Equity, a growth equity firm that supported Definitive Healthcare's scaling
• Academic Relationships: Regular speaker and mentor at Boston College (alma mater) and Harvard Business School community